Literature DB >> 10674972

Lack of a strong association of CTLA-4 exon 1 polymorphism with the susceptibility to rheumatoid arthritis and systemic lupus erythematosus in Japanese: an association study using a novel variation screening method.

M Matsushita1, N Tsuchiya, M Shiota, T Komata, K Matsuta, K Zama, T Oka, T Juji, A Yamane, K Tokunaga.   

Abstract

CTLA-4 is considered to be one of the attractive candidates for the susceptibility genes to rheumatic diseases. In the present study, the association of CTLA-4 polymorphism with rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) was examined in the Japanese population using the case-control association analysis. Polymerase chain reaction-preferential homoduplex formation assay (PCR-PHFA) was applied for the screening of genetic variations and for the genotyping of a large number of samples. A greater proportion of Japanese patients with RA (44%) and SLE (44%) compared with healthy individuals (37%) had exon 1 49 G/G genotype, but the difference did not reach statistical significance. However, when the patients with RA and healthy individuals were stratified according to HLA-DRB1 alleles, a weakly significant increase of the positivity of CTLA-4 49G allele was observed in HLA-DRB1*0405-positive patients (87%) compared with DRB1*0405-positive healthy individuals (71%) (P = 0.014, odds ratio = 2.77). These results indicate that CTLA-4 exon 1 polymorphism does not contribute greatly to the susceptibility to RA and SLE, at least in Japanese, although the presence of CTLA4 49G allele could be a minor predisposing factor for RA in HLA-DRB1*0405-positive individuals. In addition, PCR-PHFA was shown to be useful for a mass screening of gene variations.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10674972     DOI: 10.1034/j.1399-0039.1999.540607.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  14 in total

1.  Polymorphisms in the CTLA-4 gene and rheumatoid arthritis susceptibility: a meta-analysis.

Authors:  Xiaobo Li; Cong Zhang; Jie Zhang; Yonggang Zhang; Zhangjun Wu; Lian Yang; Zhangpeng Xiang; Zhanzhong Qi; Xin Zhang; Xingqiong Xiao
Journal:  J Clin Immunol       Date:  2012-02-23       Impact factor: 8.317

2.  CTLA-4 polymorphisms and systemic lupus erythematosus (SLE): a meta-analysis.

Authors:  Young Ho Lee; John B Harley; Swapan K Nath
Journal:  Hum Genet       Date:  2005-02-02       Impact factor: 4.132

3.  Association between CTLA-4 exon-1 +49A/G polymorphism and systemic lupus erythematosus: an updated analysis.

Authors:  Wei-Wei Chang; Liu Zhang; Ying-Shui Yao; Hong Su
Journal:  Mol Biol Rep       Date:  2012-06-21       Impact factor: 2.316

4.  CTLA4 is differentially associated with autoimmune diseases in the Dutch population.

Authors:  Alexandra Zhernakova; Peter Eerligh; Pilar Barrera; Joanna Z Wesoly; Joanna Z Weseloy; Tom W J Huizinga; Bart O Roep; Cisca Wijmenga; Bobby P C Koeleman
Journal:  Hum Genet       Date:  2005-07-16       Impact factor: 4.132

5.  Association between the CTLA-4 +49 A/G polymorphism and susceptibility to rheumatoid arthritis: a meta-analysis.

Authors:  Young Ho Lee; Sang-Cheol Bae; Sung Jae Choi; Jong Dae Ji; Gwan Gyu Song
Journal:  Mol Biol Rep       Date:  2011-12-18       Impact factor: 2.316

6.  Cytotoxic T lymphocyte-Associated Antigen +49G Variant Confers Risk for Anti-CCP- and Rheumatoid Factor-Positive Type of Rheumatoid Arthritis Only in Combination with CT60G Allele.

Authors:  Bernadett Farago; Peter Kisfali; Lili Magyari; Noemi Polgar; Bela Melegh
Journal:  Autoimmune Dis       Date:  2009-08-27

7.  Overexpression and secretion of the soluble CTLA-4 splice variant in various autoimmune diseases and in cases with overlapping autoimmunity.

Authors:  Suad AlFadhli
Journal:  Genet Test Mol Biomarkers       Date:  2013-02-28

8.  CTLA-4 polymorphisms and systemic lupus erythematosus: a comprehensive meta-analysis.

Authors:  Jie Liu; Hong-Xin Zhang
Journal:  Genet Test Mol Biomarkers       Date:  2013-01-05

9.  CTLA-4 polymorphisms and systemic lupus erythematosus (SLE): a meta-analysis.

Authors:  Jin-Xia Zhai; Li-Wei Zou; Zhao-Xiang Zhang; Wen-Jing Fan; Han-Yong Wang; Ting Liu; Zheng Ren; Rui-Xue Dai; Dongqing Ye
Journal:  Mol Biol Rep       Date:  2013-08-07       Impact factor: 2.316

10.  The ITGAV rs3738919 variant and susceptibility to rheumatoid arthritis in four Caucasian sample sets.

Authors:  Jade E Hollis-Moffatt; Kerry A Rowley; Amanda J Phipps-Green; Marilyn E Merriman; Nicola Dalbeth; Peter Gow; Andrew A Harrison; John Highton; Peter B B Jones; Lisa K Stamp; Pille Harrison; B Paul Wordsworth; Tony R Merriman
Journal:  Arthritis Res Ther       Date:  2009-10-09       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.